A Physician’s Plea for Exemption: Full Text 

Immunity offered by the vaccine is not long-lasting and the protection rapidly diminishes each month following the first 2 months after the second dose. With no randomized controlled trials evaluating the efficacy of the boosters on relevant clinical outcomes, and no data on safety given that the booster studies released did not contain a control group. A practitioner of science cannot be confident the potential rare benefit of hospital reduction in the younger healthy population outweighs repetitive dosing of a vaccine with limited safety data.